Ina Kramer

Author PubWeight™ 15.02‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Peripheral NT3 signaling is required for ETS protein expression and central patterning of proprioceptive sensory afferents. Neuron 2003 1.91
2 Control of the SOST bone enhancer by PTH using MEF2 transcription factors. J Bone Miner Res 2007 1.74
3 Bone overgrowth-associated mutations in the LRP4 gene impair sclerostin facilitator function. J Biol Chem 2011 1.63
4 Sclerostin deficiency is linked to altered bone composition. J Bone Miner Res 2014 1.49
5 Reversing LRP5-dependent osteoporosis and SOST deficiency-induced sclerosing bone disorders by altering WNT signaling activity. J Bone Miner Res 2014 1.42
6 Control of neuronal phenotype: what targets tell the cell bodies. Trends Neurosci 2004 1.04
7 Ubiquitous overexpression of Hey1 transcription factor leads to osteopenia and chondrocyte hypertrophy in bone. Bone 2009 1.02
8 Anti-sclerostin antibody treatment in a rat model of progressive renal osteodystrophy. J Bone Miner Res 2015 0.95
9 Drosophila p27Dacapo expression during embryogenesis is controlled by a complex regulatory region independent of cell cycle progression. Development 2002 0.93
10 Characterization of two Runx1-dependent nociceptor differentiation programs necessary for inflammatory versus neuropathic pain. Mol Pain 2010 0.90
11 Isolation of mouse osteocytes using cell fractionation for gene expression analysis. Methods Mol Biol 2012 0.85
12 Tyrosine kinase inhibitor NVP-BGJ398 functionally improves FGFR3-related dwarfism in mouse model. J Clin Invest 2016 0.80
13 Characterization of a thy1.2 GFP transgenic mouse reveals a tissue-specific organization of the spinal dorsal horn. Genesis 2007 0.79